New Narcolepsy Questionnaire Passes Its Toughest Test Yet in Phase 3 Trials
A 28-item patient-reported questionnaire measuring the real-life functional toll of narcolepsy has been validated in two phase 3 clinical trials, ...
A 28-item patient-reported questionnaire measuring the real-life functional toll of narcolepsy has been validated in two phase 3 clinical trials, ...
A new review concludes that response shift, the changing of patients' internal standards and values over time, is a genuine ...
A new review argues that the dense data generated in neonatal intensive care units could close the evidence gap for ...
A new methodological review argues that inflated placebo responses in supportive oncology symptom trials stem from identifiable, design-sensitive mechanisms that ...
An analysis of 254 registered clinical trials shows digital therapeutics are dominated by mobile apps targeting psychiatric disorders, while fragmented ...
A new review in Cellular and Molecular Life Sciences proposes hybrid biological-digital tumor twins, coupling patient-derived organoids with computational models ...
An international expert workshop has prioritised targets and trial designs to break the three-decade therapeutic stalemate in desmoplastic small round ...
A systematic review of 21 studies finds that trusted community venues, bilingual communication, culturally congruent facilitators and co-produced study designs ...
A new Cochrane review finds the evidence too uncertain to determine whether medical cannabis improves sleep or daytime functioning in ...
A new editorial argues that while intensive diet and exercise programs can achieve meaningful weight loss in men on active ...
A new Pediatric Research reflection by Alex Smith traces nearly twenty years of living alongside his son Harrison's Duchenne muscular ...
A new Aging Cell study shows that single-clock reports of biological age reversal often fail when tested against multiple epigenetic ...
A new systematic review finds that phosphodiesterase-4 inhibitors achieved clinical response in 53.4 percent of hidradenitis suppurativa patients with a ...
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer ...
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
A new analysis argues that the subacute phase after spinal cord injury is a critical but underused window for exercise ...
A landmark autopsy study of 2,550 brains shows APOE-ε4 drives medial temporal tau through amyloid-β while women's tau burden persists ...
A new review in the Journal of Neurology charts the rapid evolution of treatments for myotonic disorders, from established sodium ...
A new time-to-event analysis of early Parkinson's disease trials shows that large, clinically meaningful worsening thresholds can be detected within ...
A Bayesian re-analysis of hundreds of published clinical trials shows that statistically negative studies can hide strong evidence of benefit ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.